The Efficacy of Curcuminoids in the  Treatment of Osteoarthritis by Malherbe, Suzanne
Abstract
Osteoarthritis (OA) is most common joint complaint in the United States, and is the
primary indication for knee replacement surgery each year1. The mainstay of
treatment includes long-term use of anti-inflammatories, often associated with
toxicity with long-term use. Therefore, this review aims to answer the question: In
patients with osteoarthritis (OA) [P], will curcuminoids [I] improve joint pain,
function, and inflammation [O] compared to standard treatment or placebo [C]?
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Overview
v OA affects ~27 million American adults each year
v Involves cartilage erosion and sclerosis of the bone, bone spur development2
v Progressive disease that gets worse with age4
Symptoms3
v <15 minute AM joint stiffness
v Joint instability
v Painful ROM, worse with activity, relieved with rest
v No systemic or extra-articular manifestations
Treatment5
v First line: anti-inflammatories, analgesics (NSAIDs, APAP)
v Adjunct therapies: cortisone injections, topical capsaicin, diclofenac gel,
assistive devices, physical therapy, braces; herbal and homeopathic remedies
v American Pharmacist Association: curcuminoid compounds in turmeric have
shown to be effective in alleviating inflammation in the joints and reducing pain
and stiffness in OA patients with a similar efficacy as a low-dose NSAID
Introduction
Methods
Literature search
v Performed October and November 2018
v Google Scholar, search terms: turmeric, osteoarthritis, clinical trial, joint pain,
inflammationà 133 results
v PubMed, search terms: turmeric, osteoarthritisà 13 results
Inclusion criteria
v Turmeric, curcuminoids, osteoarthritis, joint pain
v Published within the past 5 years
Exclusion criteria
v Investigated other compounds
v Investigated other diseases
v Did not use human subjects
v Systematic reviews or meta-analyses
A total of 7 articles met criteria and were included in this analysis
All of the studies found that curcuminoids positively impact
disease progression and reduce joint pain and
inflammation for patients with OA.
Strengths
• 7/7 studies had adequate methods of blinding and recruitment
• 7/7 studies yielded statistically significant results
• Limited drug interactions
• Limited to no side effects
Limitations
• Small sample sizes
• Only 1 study had N > 200, most were ~50
• Short timelines/duration of treatment
• 2 studies had longest duration of 3 months, the rest were 1-2
months
• Lack of direct comparison to standard treatment regimens
• 4 studies compared to placebo
• 1 study compared to healthy participant
• 1 study compared to supportive care
• 1 study had no comparison
Future Research
• Compare curcuminoids to standard treatment
• Cost-effectiveness
• Long-term effects of curcuminoid supplementation
• Possibility of use as monotherapy
Discussion
Table 1. Summary of Study Designs
Results 
The Efficacy of Curcuminoids in the 
Treatment of Osteoarthritis
Curcuminoids have been utilized to reduce pain and inflammation in homeopathic
and traditional medicine for hundreds of years. However, although expanding,
there is a limited body of research surrounding the efficacy of curcuminoids in
treating inflammatory conditions such as OA. The seven studies included in this
analysis found significant improvement in joint pain and interference with ADLs in
patients with OA as well as significant reductions in both general inflammatory
biomarkers and OA-specific biomarkers. Compared to placebo, curcuminoids are
promising, however future research should be conducted to compare
curcuminoids to NSAIDs in their ability to provide symptom relief and slow disease
progression. The current research provides a promising baseline, and future
research is warranted to discern whether curcuminoids are a viable option for
alternative and adjunct treatment for patients with OA.
Conclusion
There is encouraging evidence that curcuminoids may be
efficacious in mitigating inflammation and reducing joint pain for
patients with OA of the knee. One study found that compared to
placebo, curcuminoids reduced serum biomarkers specific to OA as
well as reduced average ratings of pain and interference in ADLs in
patients with OA of the knee (Henrotin et al., 2014)6. Another study
found that curcuminoids yield statistically significant reductions in
serum inflammatory biomarkers compared to placebo (Haroyan, et
al., 2018)2. Overall, the studies showed significant improvements in
symptoms and reductions in biochemical disease processes in OA
patients supplemented with curcuminoids.
Study Design Total N Control Tx Regimen Outcome 
Measure
Haroyan A, et 
al.
RCT 201 Placebo 1 capsule (500 mg) PO 
TID x 12 weeks 
WOMAC, ESR, 
CRP, PPM
Panahi Y, et 
al. (2014)
RCT 53 Placebo 1 capsule (500 mg) PO 
TID x 6 weeks
WOMAC, VAS, 
LPFI
Panahi Y, et 
al. (2015)
RCT 53 Placebo 1 capsule (500 mg) PO 
TID x 6 weeks
SOD, GSH, 
MDA
Henrotin Y, et 
al.
Clinical 
trial
22 None 3 capsules (42 mg) PO 
BID x 3 months 
Coll-2-1, Coll-2-
1NO2, Fib3-1, 
Fib3-2, CRP, 
CTX-II, MPO, 
VAS
Panda, S. K., 
et al.
RCT 50 Placebo 500 mg PO daily x 60 
days 
WOMAC, VAS
Belcaro G, et 
al.
Registry 56 Supportive 
measures 
500 mg PO TID x 4 
weeks
KS, FRAS, 
CRP
Zeng, J., et al. Case-
control
45 Healthy patient Concentrations of 
curcumin (0, 5, 10, 20, 
and 40 μmol/L)
MMP3 gene 
expression
Study Improvement in joint 
function
Improvement 
in joint pain
Reduction of 
Biomarkers of OA
Reduction of 
Inflammatory 
Markers
Total 
Haroyan A, et al. SS SS SS SS SS
Panahi Y, et al. 
(2014)
SS SS ND ND SS
Panahi Y, et al. 
(2015)
ND ND SS SS SS
Henrotin Y, et al. ND SS SS SS SS
Panda, S. K., et al. SS SS ND ND SS
Belcaro G, et al. SS ND SS SS SS
Zeng, J., et al. ND ND SS SS SS
Key: RCT: Randomized Control Trial, WOMAC: Western Ontario and McMaster Universities Arthritis Index, PPM:
Physical Performance Measures, VAS: Visual Analog Scale, ESR: Erythrocyte Sedimentation Rate, LPFI:
Lequesne’s Pain Functional Index, ACR: American College of Rheumatology, SOD: Superoxide Dismutase,
GSH: Reduced Glutathione, MDA: Malondialdehyde, Coll2-1: specific biomarker of OA, Coll-2-1NO2: specific
biomarker of OA, Fib3-1: potential biomarker of OA, Fib3-2: potential biomarker of OA, CRP: C-reactive Protein,
CTX-II: Urinary C-Terminal Telopeptides of Type II Collagen, MPO: myeloperoxidase, KS: Karnofsky Scale
Score, FRAS: measurement of serum oxidative stress biomarkers, MMP3: matrix metalloproteinase-3 gene
Table 2. Significance of Study Results 
Key: SS = Statistically Significant, NS = Not Significant, ND = No Data Available
https://novusspinecenter.com/pain-conditions/osteoarthritis
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